Page last updated: 2024-10-19

hexadecanal and Obesity

hexadecanal has been researched along with Obesity in 1 studies

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Drummen, M1
Tischmann, L1
Gatta-Cherifi, B1
Cota, D1
Matias, I1
Raben, A1
Adam, T1
Westerterp-Plantenga, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
PREVention of Diabetes Through Lifestyle Intervention and Population Studies in Europe and Around the World[NCT01777893]2,500 participants (Anticipated)Interventional2013-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for hexadecanal and Obesity

ArticleYear
Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study.
    The Journal of clinical endocrinology and metabolism, 2020, 07-01, Volume: 105, Issue:7

    Topics: Adipose Tissue; Adult; Aged; Aldehydes; Arachidonic Acids; Body Mass Index; Endocannabinoids; Energy

2020